Scarica l'app Stockscreener
6.11
0.66%
0.04
Pre-mercato:
5.87
-0.24
-3.93%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CVRX Giù?
Forum
Previsione
Precedente Chiudi:
$6.07
Aprire:
$6.13
Volume 24 ore:
245.91K
Relative Volume:
0.72
Capitalizzazione di mercato:
$162.13M
Reddito:
$56.65M
Utile/perdita netta:
$-53.31M
Rapporto P/E:
-2.9889
EPS:
-2.0442
Flusso di cassa netto:
$-40.75M
1 W Prestazione:
+2.00%
1M Prestazione:
-23.43%
6M Prestazione:
-37.97%
1 anno Prestazione:
-8.12%
Intervallo 1D:
$6.09
$6.43
Intervallo di 1 settimana:
$5.70
$6.43
Portata 52W:
$4.3701
$11.30
Cvrx Inc Stock (CVRX) Company Profile
Nome
Cvrx Inc
Settore
Industria
Telefono
(763) 416-2850
Indirizzo
9201 WEST BROADWAY AVENUE, MINNEAPOLIS
Compare CVRX vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CVRX
Cvrx Inc
|
6.11 | 161.07M | 56.65M | -53.31M | -40.75M | -2.0442 |
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Cvrx Inc Stock (CVRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-09 | Downgrade | JP Morgan | Neutral → Underweight |
| 2025-01-14 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-09-10 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-07-11 | Reiterato | Lake Street | Buy |
| 2024-05-01 | Ripresa | Craig Hallum | Buy |
| 2024-05-01 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-05-01 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-01-31 | Iniziato | Lake Street | Buy |
| 2022-07-18 | Iniziato | Craig Hallum | Buy |
| 2021-07-26 | Iniziato | Canaccord Genuity | Buy |
| 2021-07-26 | Iniziato | Piper Sandler | Overweight |
| 2021-07-26 | Iniziato | William Blair | Outperform |
Mostra tutto
Cvrx Inc Borsa (CVRX) Ultime notizie
CVRx stock up on Humana's Medicare coverage for Barostim therapy - MSN
Understanding Momentum Shifts in (CVRX) - Stock Traders Daily
CVRx, Inc.Common Stock (NQ: CVRX - The Chronicle-Journal
Clinical research teams accelerate progress in treatment options, CVRx asserts - Traders Union
What Humana (HUM)'s Expanded Barostim Coverage Means For Shareholders - simplywall.st
CVRx to present at William Blair Growth Stock Conference on June 2, 2026 - Pluang
CVRx to Present at the William Blair 46th Annual Growth Stock Conference - The Manila Times
CVRx marks 25th Barostim implant milestone at UNC Medical Center Chapel Hill - Traders Union
CVRx Stock Up on Humana's Medicare Coverage for Barostim Therapy - Yahoo Finance
CVRx rebounds as Humana issues Medicare policy for Barostim - MSN
CVRx Inc stock (US12674F1003): Medtronic takeover bid puts heart-device specialist in the spotlight - AD HOC NEWS
Number of shareholders of CVRx, Inc. – NASDAQ:CVRX - TradingView
CVRx Gains Momentum With Revenue Growth, BENEFIT-HF Progress and Humana Coverage Win - TipRanks
CVRx (CVRX) reports Q1 loss, beats revenue estimates - MSN
The CVRx, Inc. (NASDAQ:CVRX) First-Quarter Results Are Out And Analysts Have Published New Forecasts - simplywall.st
Analysts Have Made A Financial Statement On CVRx, Inc.'s (NASDAQ:CVRX) First-Quarter Report - Yahoo Finance
CVRx Announces Humana Medicare Advantage Coverage Policy for Barostim Therapy - Sahm
Humana (HUM) Expands Medicare Advantage Coverage for Barostim Th - GuruFocus
CVRx earns Humana Medicare Advantage win for Barostim - MassDevice
CVRx stock gains as Humana to cover Barostim - Seeking Alpha
Humana issues Medicare Advantage coverage for CVRx Barostim therapy By Investing.com - Investing.com Nigeria
Humana issues Medicare Advantage coverage for CVRx Barostim therapy - Investing.com
Humana expands Barostim therapy access via Medicare Advantage, CVRx secures national deal - Traders Union
CVRx announces Humana Medicare Advantage coverage policy for Barostim therapy - marketscreener.com
Lake Street Maintains CVRx Inc(CVRX.US) With Buy Rating, Maintains Target Price $14 - Moomoo
CVRx Inc | 10-Q: Q1 2026 Earnings Report - Moomoo
Down 31.7% in 4 Weeks, Here's Why You Should You Buy the Dip in CVRx (CVRX) - Yahoo Finance
TradingKey - TradingKey
CVRx Earnings Call Highlights Growth Amid Ongoing Losses - The Globe and Mail
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
CVRx stock (US12674F1003): Q1 revenue jumps 20% to $14.8M - AD HOC NEWS
Lake Street Initiates CVRx Inc(CVRX.US) With Buy Rating, Announces Target Price $14 - Moomoo
J.P. Morgan Maintains CVRx Inc(CVRX.US) With Sell Rating, Maintains Target Price $6 - Moomoo
A Quick Look at Today's Ratings for CVRx Inc(CVRX.US), With a Forecast Between $6 to $12 - Moomoo
CVRx, Inc. (NASDAQ:CVRX) Q1 2026 Earnings Call Transcript - Insider Monkey
CVRx revenue up 20% to USD 14.8M in Q1 2026 - Medical Buyer
CVRx, Inc. 1Q 2026: Revenue $14.77M, EPS ($0.5) — 10-Q Summary - TradingView
CVRx (NASDAQ: CVRX) grows Q1 revenue 20% as net loss narrows - Stock Titan
Avoiding Lag: Real-Time Signals in (CVRX) Movement - Stock Traders Daily
CVRx earnings beat by $0.02, revenue topped estimates By Investing.com - Investing.com South Africa
Earnings call transcript: CVRx beats Q1 2026 forecasts, stock rises By Investing.com - Investing.com Australia
CVRx Q1 Earnings Call Highlights - sharewise.com
Earnings call transcript: CVRx beats Q1 2026 forecasts, stock rises - Investing.com India
CVRx revenue rises 20 percent in first quarter as U.S. operations expand - Traders Union
CVRX: Q1 2026 delivered strong revenue growth, margin expansion, and strategic progress in U.S. heart failure therapy - TradingView
CVRx (CVRX) Q1 2026 Earnings Call Transcript - AOL.com
CVRX: Q1 2026 revenue grew 20% with strong U.S. performance and improved gross margin - TradingView
CVRx (CVRX) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance
Cvrx Inc Azioni (CVRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.22%
1.41%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):